Literature DB >> 30838418

Difficult to Treat: Do We Need a New Definition?

Roger M Echols1, Glenn S Tillotson2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30838418     DOI： 10.1093/cid/ciz184

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Reply to Raoult and Rolain, and to Echols and Tillotson.

Authors:  Sameer S Kadri; Robert L Danner
Journal:  Clin Infect Dis       Date:  2019-10-15       Impact factor: 9.079

2.  Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections.

Authors:  Maddalena Giannella; Linda Bussini; Renato Pascale; Michele Bartoletti; Matteo Malagrinò; Livia Pancaldi; Alice Toschi; Giuseppe Ferraro; Lorenzo Marconi; Simone Ambretti; Russell Lewis; Pierluigi Viale
Journal:  Open Forum Infect Dis       Date:  2019-12-12       Impact factor: 3.835

3.  The Burden of Bloodstream Infections due to Stenotrophomonas Maltophilia in the United States: A Large, Retrospective Database Study.

Authors:  Bin Cai; Glenn Tillotson; Darrin Benjumea; Patrick Callahan; Roger Echols
Journal:  Open Forum Infect Dis       Date:  2020-04-22       Impact factor: 3.835

4.  Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study.

Authors:  Jeffrey R Strich; Sarah Warner; Yi Ling Lai; Cumhur Y Demirkale; John H Powers; Robert L Danner; Sameer S Kadri
Journal:  Lancet Infect Dis       Date:  2020-06-04       Impact factor: 71.421
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.